Sun Pharmaceutical Industries Ltd rose for a third straight session today. The stock is quoting at Rs 1725.7, up 2.56% on the ...

Looking for stocks to buy today? Market experts Raja Venkatraman, Trade Brains Portal, and MarketSmith India share their best stock picks for 15 July.

Join our Computer System Validation Boot Camp to master FDA regulations, including 21 CFR Part 11, and gain hands-on experience in validation projects. Register to secure training materials, live ...

Shares of Sun Pharmaceutical Industries climbed nearly 3 per cent on Tuesday after the firm said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for sev ...

LinkedIn’s Cities on the Rise 2025 report spotlights India’s fastest-growing job markets beyond metros. Tier 2 and 3 cities ...

LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...

Calling upon all relevant stakeholders to position local pharmaceutical manufacturing as a ‘thrust industry’ which can reduce ...

LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August 4, 2025. Mitch joins LabConnect with proven experience as Chief Financial Officer ...

Brigade Enterprises Ltd., Deepak Fertilizers and Petrochemicals Corp., Sun Pharmaceutical Industries Ltd. and AstraZeneca ...

Sun Pharma settles litigation with Incyte over Leqselvi, launches product for severe alopecia areata treatment in the US.

LEQSELVI has shown rapid results in clinical trials, with one-third of patients regaining nearly full scalp hair by Week 24.

Sun Pharmaceutical Industries has reached a settlement with Incyte Corporation regarding the Leqselvi drug, used for severe ...